| Irreversible electroporation combined with checkpoint blockade and TLR7 stimulation induces antitumor immunity in a murine pancreatic cancer model JSS Narayanan, P Ray, T Hayashi, TC Whisenant, D Vicente, DA Carson, ... Cancer immunology research 7 (10), 1714-1726, 2019 | 88 | 2019 |
| Doxorubicin conjugated to immunomodulatory anticancer lactoferrin displays improved cytotoxicity overcoming prostate cancer chemo resistance and inhibits tumour development in … JS Shankaranarayanan, JR Kanwar, AJA Al-Juhaishi, RK Kanwar Scientific reports 6 (1), 1-16, 2016 | 62 | 2016 |
| Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis D Ozmadenci, JS Shankara Narayanan, J Andrew, M Ojalill, AM Barrie, ... Proceedings of the National Academy of Sciences 119 (17), e2117065119, 2022 | 46 | 2022 |
| Aptamer-based therapeutics of the past, present and future: from the perspective of eye-related diseases JR Kanwar, JS Shankaranarayanan, S Gurudevan, RK Kanwar Drug discovery today 19 (9), 1309-1321, 2014 | 45 | 2014 |
| Identification of unprecedented anticancer properties of high molecular weight biomacromolecular complex containing bovine lactoferrin (HMW-bLf) F Ebrahim, JS Shankaranarayanan, JR Kanwar, S Gurudevan, ... PloS one 9 (9), e106568, 2014 | 37 | 2014 |
| Fabrication of boron nitride nanotube–gold nanoparticle hybrids using pulsed plasma in liquid SB Ponraj, Z Chen, LH Li, JS Shankaranarayanan, GD Rajmohan, ... Langmuir 30 (35), 10712-10720, 2014 | 21 | 2014 |
| Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an … JSS Narayanan, T Hayashi, S Erdem, S McArdle, H Tiriac, P Ray, M Pu, ... Journal for ImmunoTherapy of Cancer 11 (1), 2023 | 19 | 2023 |
| Anti-KIT DNA Aptamer for Targeted Labeling of Gastrointestinal Stromal Tumor S Banerjee, H Yoon, M Yebra, CM Tang, M Gilardi, ... Molecular cancer therapeutics 19 (5), 1173-1182, 2020 | 11 | 2020 |
| A syngeneic pancreatic cancer mouse model to study the effects of irreversible electroporation JSS Narayanan, P Ray, I Naqvi, R White Journal of Visualized Experiments: JoVE, 57265, 2018 | 10 | 2018 |
| Pressure-enabled delivery of gemcitabine in an orthotopic pancreatic cancer mouse model JSS Narayanan, DA Vicente, P Ray, LF Chai, S Erdem, MJ Carr, ... Surgery 168 (3), 448-456, 2020 | 4 | 2020 |
| Pressure-Enabled Drug Delivery (PEDD) of a class C TLR9 agonist in combination with checkpoint inhibitor therapy in a murine pancreatic cancer model BA Capacio, JSS Narayanan, DA Vicente, Y Liu, JP LaPorte, BF Cox, ... Surgery 174 (3), 666-673, 2023 | 3 | 2023 |
| Local ablative therapies and the effect on antitumor immune responses in pancreatic cancer–A review S Erdem, JS Narayanan, M Worni, M Bolli, RR White Heliyon 10 (1), 2024 | 2 | 2024 |
| Comparison of gemcitabine delivery and tumor response in a pressurized pancreatic retrograde venous infusion versus systemic infusion in an orthotopic murine model. D Vicente, J Shankara Narayanan, P Ray, LF Chai, S Erdem, M Carr, ... Journal of Clinical Oncology 38 (4_suppl), 737-737, 2020 | 2 | 2020 |
| Oxaliplatin-induced peripheral neuropathy can be minimized by pressurized regional intravascular delivery in an orthotopic murine pancreatic cancer model JSN Shankara Narayanan, K Frizzi, S Erdem, P Ray, D Jaroch, B Cox, ... Discover Oncology 13 (1), 21, 2022 | 1 | 2022 |
| Irreversible electroporation is an" in situ vaccine" and induces antitumor immune responses in pancreatic cancer. JSS Narayanan, A Miller, T Hayashi, P Ray, S Schoenberger, D Carson, ... CANCER IMMUNOLOGY RESEARCH 8 (4), 45-46, 2020 | 1 | 2020 |
| Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits … JS Shankaranarayanan, JR Kanwar, AJ Abd AL-Juhaishi, RK Kanwar Scientific Reports 9, 2019 | 1 | 2019 |
| Aptamers for Nano-Delivery N Akhtar, S Chaudhary, JSNS Narayanan, AJ Abd, J MacDonald, ... NanoBioEngineering, 93-121, 2018 | 1 | 2018 |
| Inhibition of SUMOylation Induces Adaptive Antitumor Immunity against Pancreatic Cancer through Multiple Effects on the Tumor Microenvironment S Erdem, HJ Lee, JSN Shankara Narayanan, MDN Tharuka, J De la Torre, ... Molecular Cancer Therapeutics 23 (11), 1597-1612, 2024 | | 2024 |
| Abstract B053: SUMOylation and TIGIT inhibition: a novel immunotherapy combination for pancreatic cancer JR de la Torre Medina, U Joshi, JS Narayanan, H Tiriac, Y Chen, R White Cancer Research 84 (17_Supplement_2), B053-B053, 2024 | | 2024 |
| Time-resolved analysis of CAR-T Cell induced apoptosis of low frequency target cells using an Image-enhanced flow cytometer was enabled by fluorescent protein compensation with … J Narayanan, E Taylor The Journal of Immunology 212 (1_Supplement), 0775_4628-0775_4628, 2024 | | 2024 |
